Alnylam Pharmaceuticals | ALNY - Ação





Ação Alterar Data
Acadia Pharmaceuticals USD 108.67M 77.1M 2026-06
Agios Pharmaceuticals USD 35.75M 665K 2026-06
Alnylam Pharmaceuticals USD 97.11M 103.04M 2026-06
Amgen USD 6.22B 34M 2026-06
Arrowhead Research USD -173.08M 173.08M 2024-12
BioCryst Pharmaceuticals USD 6.06M 71K 2026-06
BioMarin Pharmaceutical USD 1.78B 509.3M 2026-06
Incyte USD 112.54M 3.08M 2026-06
Ionis Pharmaceuticals USD 50.83M 45.28M 2026-06
Moderna USD 280M 134M 2026-06
Neurocrine Biosciences USD 104.2M 39.7M 2026-06
Novartis USD 6.29B 135M 2026-03
PTC Therapeutics USD 91.35M 15.79M 2026-06
Regeneron Pharmaceuticals USD 3.08B 19.3M 2026-06
Sanofi EUR 23.5B 812M 2026-03
Sarepta Therapeutics USD 904.27M 96.84M 2026-06
Takeda JPY 1.45T 50.64B 2026-06
Ultragenyx Pharmaceutical USD 59M 4M 2026-06
Vertex Pharmaceuticals USD 1.77B 1.6M 2026-06